Sort
30,917 grants matching “tumor microenvironment”
Enabling NF-kB Signal Transduction Studies in Primary Multiple Myeloma Cells
$281,059Shigeki Miyamoto · University Of Wisconsin-Madison · R01 · FY2015 · CA
Enabling NF-kB Signal Transduction Studies in Primary Multiple Myeloma Cells
$281,059Shigeki Miyamoto · University Of Wisconsin-Madison · R01 · FY2016 · CA
The CXCR4-SDF-1 Axis in Metastatic Rhabdomyosarcoma
$281,043University Of Louisville · R01 · FY2005 · CA
Project 2: Overcoming Microenvironment-Mediated Resistance to AR Pathway Inhibition in High-Risk Prostate Cancer
$280,975Brett Stewart Carver · Sloan-Kettering Inst Can Research · P50 · FY2024 · CA
Reversing/Blocking T cell suppression by extracellular vesicles as cancer therapy
$280,928Maulasri Bhatta · Immune Modulatory Therapies, Llc · R43 · FY2018 · CA
Role of cPLA2 in Lung Cancer: Microenvironment vs Tumor Cells
$280,917Raphael A. Nemenoff · University Of Colorado Denver · R01 · FY2010 · CA
OVERCOMING TUMOR EVASION MECHANISMS IN HODGKIN DISEASE
$280,910Cliona M Rooney · Baylor College Of Medicine · P01 · FY2010 · CA
Novel Methods for Detecting Cell Interactions in the Tumor Microenvironment
$280,899John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2007 · CA
Retinoid Nutritional Status and Immune Function
$280,893A Catharine Ross · Pennsylvania State University, The · R01 · FY2010 · DK
Mechanisms of Macrophage Activation
$280,880Thomas Alan Hamilton · Cleveland Clinic Lerner Com-Cwru · R01 · FY2007 · CA
Role of an Epithelial Ets Factor in Breast Cancer
$280,880Medical University Of South Carolina · R01 · FY2004 · CA
Mechanisms of Macrophage Activation
$280,880Thomas Alan Hamilton · Cleveland Clinic Lerner Com-Cwru · R01 · FY2006 · CA
DEVELOPMENTAL FUNDS
$280,873Paul A Bunn · University Of Colorado Denver · P30 · FY2013 · CA
Role of Stat3 in Tumor Immune Evasion and Immune Suppression
$280,866Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2014 · CA
Systemic Inhibition of Monocyte Chemoattractant Protein-1 (MCP-1; CCL2)
$280,834Robert Loberg · University Of Michigan At Ann Arbor · P50 · FY2010 · CA
Project 1: Modeling the Interface between Non-invasive Imaging and Drug Distribution
$280,807Kristin R Swanson · Massachusetts Institute Of Technology · U54 · FY2017 · CA
Safety and Efficacy of Vemurafenib and High-Dose InterferonAlpha-2b for Advanced Melanoma
$280,797Hassane M Zarour · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · CA
Project 4: Targeting Resistance to T-Cell Directed Therapy in Multiple Myeloma
$280,796Yi Lin · Mayo Clinic Arizona · P50 · FY2025 · CA
Design, Synthesis, and Evaluation of ant-Glioblastoma Agents
$280,786Paul E Floreancig · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · GM
Project 4. Targeting genomic instability and evolution in myeloma
$280,769Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Project 4. Targeting genomic instability and evolution in myeloma
$280,767Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Project 4. Targeting genomic instability and evolution in myeloma
$280,767Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2018 · CA
Project 4. Targeting genomic instability and evolution in myeloma
$280,767Nikhil C. Munshi · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Immunotherapy of Advanced Non-small Cell Lung Cancer
$280,764Lieping Chen · Yale University · P50 · FY2019 · CA
Microbial Dysbiosis in Pancreatic Cancer Initiation and Progression
$280,670Donnele Daley · University Of Michigan At Ann Arbor · K08 · FY2023 · CA